{{Rsnum
|rsid=12625057
|Gene=ZNF831
|Chromosome=20
|position=59215381
|Orientation=plus
|GMAF=0.1166
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=ZNF831
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 83.2 | 16.8 | 0.0
| HCB | 59.9 | 31.4 | 8.8
| JPT | 64.6 | 31.0 | 4.4
| YRI | 100.0 | 0.0 | 0.0
| ASW | 98.2 | 1.8 | 0.0
| CHB | 59.9 | 31.4 | 8.8
| CHD | 51.9 | 39.8 | 8.3
| GIH | 86.1 | 13.9 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 60.3 | 34.5 | 5.2
| MKK | 94.9 | 5.1 | 0.0
| TSI | 84.2 | 15.8 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19875103
|Trait=Response to antipsychotic therapy (extrapyramidal side effects)
|Title=Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
|RiskAllele=
|Pval=0.000007
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs12625057
|overall_frequency_n=9
|overall_frequency_d=128
|overall_frequency=0.0703125
|n_genomes=9
|n_genomes_annotated=0
|n_haplomes=9
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}